COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00916123
Brief Title: Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer

First Submitted : June 5, 2009
First Submitted that Met QC Criteria : June 5, 2009
First Posted : June 9, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : September 5, 2019
Last Update Posted : September 9, 2019